M RE4 (Ropinirole hydrochloride extended-release 4 mg)
Pill imprint M RE4 has been identified as Ropinirole hydrochloride extended-release 4 mg.
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
More about ropinirole
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.